Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Varithena vs Endothermal Ablation for Great Saphenous Vein
NCT05312970Phase 4Terminated
- Sponsor
- Boston Scientific Corporation
- Start
- Feb 2023
- Primary completion
- Apr 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of polidocanol in Varicose Veins (2 arms), sponsored by Boston Scientific Corporation. Primary endpoint: Change in Varicose Veins Symptoms Questionnaire at 3 months. Started Feb 2023; status: terminated.
02
Drugs
polidocanol
03
Conditions
Varicose Veins
Beyond the preview
Go deeper on NCT05312970.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05312970.